2018 Q1 Form 10-Q Financial Statement

#000156459018011803 Filed on May 08, 2018

View on sec.gov

Income Statement

Concept 2018 Q1 2017 Q1
Revenue $378.0M $372.0M
YoY Change 1.61% 5.68%
Cost Of Revenue $20.00M $17.00M
YoY Change 17.65% 6.25%
Gross Profit $358.0M $355.0M
YoY Change 0.85% 5.65%
Gross Profit Margin 94.71% 95.43%
Selling, General & Admin $307.0M $301.0M
YoY Change 1.99% 11.48%
% of Gross Profit 85.75% 84.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.00M $27.00M
YoY Change -25.93% 12.5%
% of Gross Profit 5.59% 7.61%
Operating Expenses $335.0M $328.0M
YoY Change 2.13% 11.56%
Operating Profit $23.00M $27.00M
YoY Change -14.81% -35.71%
Interest Expense $3.000M -$2.000M
YoY Change -250.0% -50.0%
% of Operating Profit 13.04% -7.41%
Other Income/Expense, Net -$2.000M -$2.000M
YoY Change 0.0%
Pretax Income $21.00M $25.00M
YoY Change -16.0% -34.21%
Income Tax $16.00M $12.00M
% Of Pretax Income 76.19% 48.0%
Net Earnings $5.000M $13.00M
YoY Change -61.54% -55.17%
Net Earnings / Revenue 1.32% 3.49%
Basic Earnings Per Share $0.04 $0.09
Diluted Earnings Per Share $0.04 $0.09
COMMON SHARES
Basic Shares Outstanding 139.3M 143.6M
Diluted Shares Outstanding 140.3M 144.7M

Balance Sheet

Concept 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $650.0M $746.0M
YoY Change -12.87% 7.8%
Cash & Equivalents $635.0M $731.0M
Short-Term Investments $15.00M $15.00M
Other Short-Term Assets $52.00M $25.00M
YoY Change 108.0% -10.71%
Inventory
Prepaid Expenses
Receivables $269.0M $232.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $983.0M $1.003B
YoY Change -1.99% 4.05%
LONG-TERM ASSETS
Property, Plant & Equipment $261.0M $262.0M
YoY Change -0.38% 3.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.000M $3.000M
YoY Change 66.67% -82.35%
Other Assets $92.00M $67.00M
YoY Change 37.31% -6.94%
Total Long-Term Assets $1.257B $1.271B
YoY Change -1.1% 1.68%
TOTAL ASSETS
Total Short-Term Assets $983.0M $1.003B
Total Long-Term Assets $1.257B $1.271B
Total Assets $2.240B $2.274B
YoY Change -1.5% 2.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $276.0M $12.00M
YoY Change 2200.0% -20.0%
Accrued Expenses $150.0M $76.00M
YoY Change 97.37% -43.28%
Deferred Revenue $59.00M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $7.000M $7.000M
YoY Change 0.0% 600.0%
Total Short-Term Liabilities $534.0M $452.0M
YoY Change 18.14% 4.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $210.0M
YoY Change -100.0% 90.91%
Other Long-Term Liabilities $300.0M $215.0M
YoY Change 39.53% 11.98%
Total Long-Term Liabilities $300.0M $425.0M
YoY Change -29.41% 40.73%
TOTAL LIABILITIES
Total Short-Term Liabilities $534.0M $452.0M
Total Long-Term Liabilities $300.0M $425.0M
Total Liabilities $850.0M $890.0M
YoY Change -4.49% 18.67%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares $9.727M $6.925M
Shareholders Equity $1.389B $1.384B
YoY Change
Total Liabilities & Shareholders Equity $2.240B $2.274B
YoY Change -1.5% 2.71%

Cashflow Statement

Concept 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income $5.000M $13.00M
YoY Change -61.54% -55.17%
Depreciation, Depletion And Amortization $20.00M $27.00M
YoY Change -25.93% 12.5%
Cash From Operating Activities $174.0M $134.0M
YoY Change 29.85% 8.06%
INVESTING ACTIVITIES
Capital Expenditures $15.00M $18.00M
YoY Change -16.67% 5.88%
Acquisitions
YoY Change
Other Investing Activities $43.00M $116.0M
YoY Change -62.93% 314.29%
Cash From Investing Activities $28.00M $98.00M
YoY Change -71.43% 790.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.000M $150.0M
YoY Change -97.33% 14900.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -246.0M -114.0M
YoY Change 115.79% 16.33%
NET CHANGE
Cash From Operating Activities 174.0M 134.0M
Cash From Investing Activities 28.00M 98.00M
Cash From Financing Activities -246.0M -114.0M
Net Change In Cash -38.00M 119.0M
YoY Change -131.93% 221.62%
FREE CASH FLOW
Cash From Operating Activities $174.0M $134.0M
Capital Expenditures $15.00M $18.00M
Free Cash Flow $159.0M $116.0M
YoY Change 37.07% 8.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000
CY2017Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2000000
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25000000
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
13000000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143632000
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144717000
CY2017Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
14000000
CY2017Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
7000000
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7000000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20000000
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
673000000
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
35000000
CY2018Q1 trip Accounts Receivable And Contract Assets Net Current
AccountsReceivableAndContractAssetsNetCurrent
281000000
CY2017Q4 trip Accounts Receivable And Contract Assets Net Current
AccountsReceivableAndContractAssetsNetCurrent
230000000
CY2017Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
7000000
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
230000000
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
14000000
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
293000000
CY2018Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
198000000
CY2017Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3000000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
177000000
CY2018Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
120000000
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
112000000
CY2018Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2018Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1600000000
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1600000000
CY2018Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
136396872
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
135617263
CY2018Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126669732
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
126142773
CY2018Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
9727140
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
9474490
CY2018Q1 us-gaap Cumulative Effect On Retained Earnings Net Of Tax1
CumulativeEffectOnRetainedEarningsNetOfTax1
4000000
CY2018Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
10000000
CY2018Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
12000000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32000000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29000000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
19000000
CY2017Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6000000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
55000000
CY2017Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
35000000
CY2017Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-8000000
CY2018Q1 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
110000000
CY2017Q1 us-gaap Increase Decrease In Customer Advances
IncreaseDecreaseInCustomerAdvances
88000000
CY2018Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
15000000
CY2018Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
42000000
CY2017Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
24000000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
174000000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
134000000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15000000
CY2017Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000000
CY2018Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1000000
CY2018Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
41000000
CY2017Q1 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
102000000
CY2018Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
3000000
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
14000000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
28000000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
98000000
CY2018Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4000000
CY2017Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150000000
CY2018Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000000
CY2017Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
13000000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-246000000
CY2017Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-114000000
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000000
CY2017Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1000000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-38000000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
119000000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
673000000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
612000000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
635000000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
731000000
CY2018Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3000000
CY2017Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3000000
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accounting Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">We use estimates and assumptions in the preparation of our unaudited condensed consolidated financial statements in accordance with GAAP. Our estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of our unaudited condensed consolidated financial statements. These estimates and assumptions also affect the reported amount of net income or loss during any period. Our actual financial results could differ significantly from these estimates. The significant estimates underlying our unaudited condensed consolidated financial statements include: (i) recognition and recoverability of goodwill, definite-lived intangibles and other long-lived assets; and (ii) accounting for income taxes.</p></div>
CY2018Q1 trip Number Of Markets With Localized Websites
NumberOfMarketsWithLocalizedWebsites
48
CY2018Q1 trip Number Of Languages Worldwide
NumberOfLanguagesWorldwide
28
CY2018Q1 trip Number Of Other Travel Brands
NumberOfOtherTravelBrands
20
CY2018Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2018Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
378000000
CY2018Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
269000000
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
230000000
CY2018Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
12000000
CY2018Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
41000000
CY2018Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
118000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
516000
CY2018Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
892000
CY2017Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
569000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29000000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000000
CY2018Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000
CY2017Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000
CY2018Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
22000000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
12000000
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0266
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0191
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y5M12D
CY2017Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M6D
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4229
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.4153
CY2018Q1 trip Income Tax Benefits Associated With Exercise Settlement Of Stock Based Awards
IncomeTaxBenefitsAssociatedWithExerciseSettlementOfStockBasedAwards
3000000
CY2017Q1 trip Income Tax Benefits Associated With Exercise Settlement Of Stock Based Awards
IncomeTaxBenefitsAssociatedWithExerciseSettlementOfStockBasedAwards
14000000
CY2018Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
635000000
CY2017Q1 trip Income Tax Reconciliation Change In Cost Sharing Treatment Of Stock Based Compensation
IncomeTaxReconciliationChangeInCostSharingTreatmentOfStockBasedCompensation
-1000000
CY2018Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
250000000
CY2018Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
252650
CY2018Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
39.88
CY2018Q1 trip Remaining Amounts Payable For Repurchase Of Common Stock Recorded In Accrued Expenses And Other Current Liabilities
RemainingAmountsPayableForRepurchaseOfCommonStockRecordedInAccruedExpensesAndOtherCurrentLiabilities
6000000
CY2018Q1 us-gaap Cash
Cash
340000000
CY2018Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
340000000
CY2018Q1 trip Cash Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost
CashCashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
655000000
CY2018Q1 trip Cash Cash Equivalents Restricted Cash And Marketable Securities Fair Value
CashCashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
655000000
CY2017Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
673000000
CY2017Q4 us-gaap Cash
Cash
663000000
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
663000000
CY2017Q4 trip Cash Cash Equivalents Restricted Cash And Marketable Securities Amortized Cost
CashCashEquivalentsRestrictedCashAndMarketableSecuritiesAmortizedCost
735000000
CY2017Q4 trip Cash Cash Equivalents Restricted Cash And Marketable Securities Fair Value
CashCashEquivalentsRestrictedCashAndMarketableSecuritiesFairValue
735000000
CY2018Q1 trip Cash And Cash Equivalents Maximum Maturity Period
CashAndCashEquivalentsMaximumMaturityPeriod
P90D
CY2017 trip Cash And Cash Equivalents Maximum Maturity Period
CashAndCashEquivalentsMaximumMaturityPeriod
P90D
CY2018Q1 trip Marketable Securities Long Term Maximum Maturity Period
MarketableSecuritiesLongTermMaximumMaturityPeriod
P3Y
CY2017 trip Marketable Securities Long Term Maximum Maturity Period
MarketableSecuritiesLongTermMaximumMaturityPeriod
P3Y
CY2018Q1 trip Marketable Securities Long Term Minimum Maturity Period
MarketableSecuritiesLongTermMinimumMaturityPeriod
P1Y
CY2017 trip Marketable Securities Long Term Minimum Maturity Period
MarketableSecuritiesLongTermMinimumMaturityPeriod
P1Y
CY2018Q1 trip Maximum Remaining Maturity Period For Short Term Securities
MaximumRemainingMaturityPeriodForShortTermSecurities
P12M
CY2017 trip Maximum Remaining Maturity Period For Short Term Securities
MaximumRemainingMaturityPeriodForShortTermSecurities
P12M
CY2018Q1 trip Minimum Maturity Period For Short Term Securities
MinimumMaturityPeriodForShortTermSecurities
P90D
CY2017 trip Minimum Maturity Period For Short Term Securities
MinimumMaturityPeriodForShortTermSecurities
P90D
CY2018Q1 trip Derivative Instruments Non Designated As Hedging Instruments Description
DerivativeInstrumentsNonDesignatedAsHedgingInstrumentsDescription
Derivative financial instruments are carried at fair value on our unaudited condensed consolidated balance sheets. We use foreign currency forward contracts to reduce the effects of foreign currency exchange rate fluctuations on our cash flows primarily for the Euro versus the U.S. Dollar. Our foreign currency forward contracts, which we have entered into to date, have not been designated as hedges and have had current maturities of less than 90 days
CY2018Q1 us-gaap Cost Method Investments
CostMethodInvestments
12000000
CY2017Q4 us-gaap Cost Method Investments
CostMethodInvestments
12000000
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.762
CY2017Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.480
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018Q1 trip Incremental Transition Tax Expense
IncrementalTransitionTaxExpense
5000000
CY2018Q1 trip Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
-1000000
CY2018Q1 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
11000000
CY2018Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2018Q1 trip Income Tax Reconciliation Change In Cost Sharing Treatment Of Stock Based Compensation
IncomeTaxReconciliationChangeInCostSharingTreatmentOfStockBasedCompensation
-1000000
CY2018Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
240000000
CY2018Q1 trip Adjusted Earnings Before Interest Taxes Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
80000000

Files In Submission

Name View Source Status
0001564590-18-011803-index-headers.html Edgar Link pending
0001564590-18-011803-index.html Edgar Link pending
0001564590-18-011803.txt Edgar Link pending
0001564590-18-011803-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trip-10q_20180331.htm Edgar Link pending
trip-20180331.xml Edgar Link completed
trip-20180331.xsd Edgar Link pending
trip-20180331_cal.xml Edgar Link unprocessable
trip-20180331_def.xml Edgar Link unprocessable
trip-20180331_lab.xml Edgar Link unprocessable
trip-20180331_pre.xml Edgar Link unprocessable
trip-ex101_73.htm Edgar Link pending
trip-ex102_74.htm Edgar Link pending
trip-ex103_75.htm Edgar Link pending
trip-ex104_76.htm Edgar Link pending
trip-ex105_77.htm Edgar Link pending
trip-ex106_78.htm Edgar Link pending
trip-ex107_79.htm Edgar Link pending
trip-ex311_6.htm Edgar Link pending
trip-ex312_7.htm Edgar Link pending
trip-ex321_10.htm Edgar Link pending
trip-ex322_8.htm Edgar Link pending